ArticleBlood advances2022

High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia.

Blachy J Dávila Saldaña et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.